» Articles » PMID: 29679336

LSG Vs MGB-OAGB-3 Year Follow-up Data: a Randomised Control Trial

Overview
Journal Obes Surg
Date 2018 Apr 22
PMID 29679336
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The objective of this study is to compare 3-year follow-up results of one anastomosis gastric bypass (MGB-OAGB) and laparoscopic sleeve gastrectomy (LSG) in terms of weight loss, complications, resolution of comorbidities and quality of life.

Materials And Methods: A prospective randomised study of results between 100 LSG patients and 101 MGB-OAGB patients was done from 2012 to 2015. The results were compared regarding operative outcomes, percentage of excess weight loss (%EWL), complications, resolution of comorbidities and quality of life (BAROS score) at 3 years follow-up.

Results: Follow-up was achieved in 93 MGB-OAGB vs 92 LSG patients for 3-year period. The average %EWL for MGB-OAGB vs LSG was 66.48 vs 61.15% at the end of 3 years respectively, which was statistically insignificant. Diabetes remission was seen in 89.13% of MGB-OAGB patients and 81.82% of LSG patients. Remission of hypertension was seen in 74% of MGB-OAGB patients and 72.22% of LSG patients. Bariatric analysis reporting and outcome system (BAROS) with comorbidity in LSG patients and MGB-OAGB patients was 6.03 and 6.96 respectively, whereas in patients without comorbidity, BAROS score was 3.86 in LSG group and 4.34 in MGB-OAGB group.

Conclusions: In our study, at 36 months follow up, there was no significant difference between LSG and MGB-OAGB in %EWL and remission of HTN. Type 2 diabetes mellitus (T2DM) remission rates were higher after MGB-OAGB as compared to LSG but the difference was statistically insignificant. MGB-OAGB patients with comorbidities have a better quality of life and BAROS score compared to LSG patients.

Citing Articles

Efficacy of One Anastomosis Gastric Bypass Versus Sleeve Gastrectomy and Roux-en-Y Gastric Bypass for the Treatment of Type 2 Diabetes Mellitus: a Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Kermansaravi M, Chiappetta S, Kassir R, Bosco A, Giudicelli X, Lainas P Obes Surg. 2024; 34(12):4555-4562.

PMID: 39496986 DOI: 10.1007/s11695-024-07564-z.


Comparative effectiveness of metabolic and bariatric surgeries: a network meta-analysis.

Malik A, Malik M, Javaid S, Qureshi S, Nadir A Int J Obes (Lond). 2024; 49(1):54-62.

PMID: 39397157 DOI: 10.1038/s41366-024-01648-7.


Anemia rates after one-anastomosis gastric bypass versus sleeve gastrectomy: a retrospective cohort study.

Romano-Zelekha O, Keren D, Herskovitz Y, Vinograd A, Globus I, Keinan-Boker L Surg Today. 2024; .

PMID: 39382701 DOI: 10.1007/s00595-024-02946-3.


EFFICACY AND SAFETY OF ONE ANASTOMOSIS GASTRIC BYPASS IN SURGICAL TREATMENT OF OBESITY: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS.

Onzi T, Junior W, Bastos E, Dantas A, Silva L, Oliveira Neto A Arq Bras Cir Dig. 2024; 37:e1814.

PMID: 39230117 PMC: 11363908. DOI: 10.1590/0102-6720202400021e1814.


LSG vs OAGB: 7-Year Follow-up Data of a Randomised Control Trial and Comparative Outcome Based on BAROS Score.

Jain M, Tantia O, Goyal G, Chaudhuri T, Khanna S, Majumdar K Obes Surg. 2024; 34(4):1295-1305.

PMID: 38427149 DOI: 10.1007/s11695-024-07114-7.


References
1.
Wang W, Wei P, Lee Y, Huang M, Chiu C, Lee W . Short-term results of laparoscopic mini-gastric bypass. Obes Surg. 2005; 15(5):648-54. DOI: 10.1381/0960892053923752. View

2.
Rutledge R, Walsh T . Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg. 2005; 15(9):1304-8. DOI: 10.1381/096089205774512663. View

3.
Sanchez-Santos R, Masdevall C, Baltasar A, Martinez-Blazquez C, de Gordejuela A, Ponsi E . Short- and mid-term outcomes of sleeve gastrectomy for morbid obesity: the experience of the Spanish National Registry. Obes Surg. 2009; 19(9):1203-10. DOI: 10.1007/s11695-009-9892-9. View

4.
Quan Y, Huang A, Ye M, Xu M, Zhuang B, Zhang P . Efficacy of Laparoscopic Mini Gastric Bypass for Obesity and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract. 2015; 2015:152852. PMC: 4488176. DOI: 10.1155/2015/152852. View

5.
Wang W, Liou T, Lee W, Hsu C, Lee M, Chen H . ESR1 gene and insulin resistance remission are associated with serum uric acid decline for severely obese patients undergoing bariatric surgery. Surg Obes Relat Dis. 2013; 10(1):14-22. DOI: 10.1016/j.soard.2012.10.011. View